Skip to main content
2024 ACRM Annual Fall Conference & EXPO Main banner
G4 Foot Drop System
REGISTER NOW
REGISTER NOW
Final Program


AT-A-GLANCE PDF
Back
Register Now

Symposium

Military and Veterans Affairs

Brain Injury

Evaluating Photobiomodulation for Traumatic Brain Injury in Veterans: A New Horizon in Treatment 0575

Sunday, November 3, 2024
8:15 AM – 9:15 AM  
Location:  ROOM: Obelisk B REGION: Atrium II Mezzanine Level >>>DIRECTIONS: Exit Atrium Elevators. Take a right and proceed down the corridor. Continue past the escalators and the row of rooms on your left. At the end of the row of rooms, turn down the corridor on the right. Obelisk B is the second room on the left. If coming from the Tower Mezzanine, from the Tower Elevators, turn right. Proceed down the stairs and take the first corridor on your left. Obelisk B is the second room on the left.
Credit Hours: Not Eligible for CE Credit
This presentation delves into the pressing issue of Traumatic Brain Injury (TBI) among veterans—a condition linked to elevated suicide rates, mental health challenges, and chronic diseases. Highlighting the substantial burden on the VA healthcare system, it explores an innovative treatment in Photobiomodulation (PBM). PBM, a low-cost, side-effect-free method using red and near-infrared light, has shown promising results in alleviating TBI symptoms such as cognitive impairments, PTSD, and depression. Initially evaluated in 2017 and gaining approval from the Veterans Health Administration, PBM's effectiveness is supported by research from VA centers. The session will cover the science behind PBM, its application, and the positive outcomes from various studies. Additionally, it addresses the future of PBM—how ongoing research and the fine-tuning of treatment parameters could enhance its efficacy and personalize care. Attendees will gain insight into a potentially transformative approach to TBI treatment, marking a significant step forward in veteran healthcare.

Upload Image

Learning Objectives:

  • Upon completion, participant will be able to use photobiomodulation (PBM) in clinical and personal practice related to traumatic brain injury (TBI).
  • Upon completion, participant will be able to express and describe the mechanisms underlying PBM relevant to treating TBI.
  • Upon completion, participant will be able to evaluate different embodiments of PBM technology as a treatment for TBI.
  • Upon completion, participant will be able to explore the future of the technology for improved outcomes in TBI recovery.
  • Upon completion, participant will be able to use photobiomodulation (PBM) in clinical and personal practice related to traumatic brain injury (TBI).
Disclosure(s):
Lew Lim, PhD., MBA: Vielight Inc.: Employment (full or part time) (Ongoing), Patent Holder (Ongoing)